Progress in BRCA-Mutated Ovarian Cancer
N Engl J Med
.
2018 Dec 27;379(26):2567-2568.
doi: 10.1056/NEJMe1812644.
Authors
David R Spriggs
1
,
Dan L Longo
1
Affiliation
1
From the Departments of Hematology-Oncology and Medicine, Harvard Medical School (D.R.S.).
PMID:
30586521
DOI:
10.1056/NEJMe1812644
No abstract available
Publication types
Editorial
Comment
MeSH terms
Carcinoma, Ovarian Epithelial
Female
Humans
Ovarian Neoplasms
Phthalazines*
Piperazines*
Substances
Phthalazines
Piperazines
olaparib